跳至主要内容
临床试验/ACTRN12616000976482
ACTRN12616000976482已完成未知

Individualised metacognitive therapy (MCT+) for delusions: A randomized controlledrater-blind study

Flinders University0 个研究点目标入组 60 人开始时间: 2016年7月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • a) Must have a DSM-5 diagnosis of a schizophrenia spectrum disorder (this will be confirmed by the ‘Psychotic Disorder’ subscale of the Mini-International Neuropsychiatric Interview or M.I.N.I).
  • b) Must hold mild to moderate delusional beliefs as a minimum; this will be confirmed by a baseline ‘Delusions’ subscale score >3 of the Positive and Negative Syndrome Scale (PANSS).
  • c) Must be able to speak, read and understand English and have the ability to respond to questions and follow instructions.

排除标准

  • a) primary diagnosis of substance use disorder
  • c) severe organic brain disorders

研究者

相似试验